BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 28189153)

  • 1. Antivirulence Properties of Probiotics in Combating Microbial Pathogenesis.
    Surendran Nair M; Amalaradjou MA; Venkitanarayanan K
    Adv Appl Microbiol; 2017; 98():1-29. PubMed ID: 28189153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens.
    Corr SC; Hill C; Gahan CG
    Adv Food Nutr Res; 2009; 56():1-15. PubMed ID: 19389605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics as functional food in the treatment of diarrhea.
    Yan F; Polk DB
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):717-21. PubMed ID: 17053425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Probiotics: history, definition, requirements and possible therapeutic applications].
    Montalto M; Arancio F; Izzi D; Cuoco L; Curigliano V; Manna R; Gasbarrini G
    Ann Ital Med Int; 2002; 17(3):157-65. PubMed ID: 12402663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges.
    Wan MLY; Forsythe SJ; El-Nezami H
    Crit Rev Food Sci Nutr; 2019; 59(20):3320-3333. PubMed ID: 29993263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and probiotic overview.
    Cremon C; Barbaro MR; Ventura M; Barbara G
    Curr Opin Pharmacol; 2018 Dec; 43():87-92. PubMed ID: 30219638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foodborne enterotoxigenic Escherichia coli: from gut pathogenesis to new preventive strategies involving probiotics.
    Roussel C; Sivignon A; de Wiele TV; Blanquet-Diot S
    Future Microbiol; 2017 Jan; 12():73-93. PubMed ID: 27983878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics, gut microbiota, and their influence on host health and disease.
    Sánchez B; Delgado S; Blanco-Míguez A; Lourenço A; Gueimonde M; Margolles A
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27500859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice.
    Grazul H; Kanda LL; Gondek D
    Gut Microbes; 2016; 7(2):101-14. PubMed ID: 26963277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics in Curing Allergic and Inflammatory Conditions - Research Progress and Futuristic Vision.
    Dhama K; Latheef SK; Munjal AK; Khandia R; Samad HA; Iqbal HMN; Joshi SK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):105-118. PubMed ID: 28029082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics in clinical conditions.
    Marteau PR
    Clin Rev Allergy Immunol; 2002 Jun; 22(3):255-73. PubMed ID: 12043384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future uses of real-time polymerase chain reaction and microarrays in the study of intestinal microbiota, and probiotic use and effectiveness.
    Carey CM; Kirk JL; Ojha S; Kostrzynska M
    Can J Microbiol; 2007 May; 53(5):537-50. PubMed ID: 17668012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of probiotic action: a proteomic perspective.
    Siciliano RA; Mazzeo MF
    Curr Opin Microbiol; 2012 Jun; 15(3):390-6. PubMed ID: 22538051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and clinical effects: is the number what counts?
    Bertazzoni E; Donelli G; Midtvedt T; Nicoli J; Sanz Y
    J Chemother; 2013 Aug; 25(4):193-212. PubMed ID: 23906073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.
    O'Shea EF; Cotter PD; Stanton C; Ross RP; Hill C
    Int J Food Microbiol; 2012 Jan; 152(3):189-205. PubMed ID: 21742394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics as drugs against human gastrointestinal infections.
    Sanz Y; Nadal I; Sánchez E
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):148-56. PubMed ID: 18221171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic mechanisms of action.
    Bermudez-Brito M; Plaza-Díaz J; Muñoz-Quezada S; Gómez-Llorente C; Gil A
    Ann Nutr Metab; 2012; 61(2):160-74. PubMed ID: 23037511
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Rodríguez-Sojo MJ; Ruiz-Malagón AJ; Rodríguez-Cabezas ME; Gálvez J; Rodríguez-Nogales A
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.